Subj: Re:Conference call number?
Date: 97-08-10 13:20:20 EDT
From: Skipard
I am sorry to say that the conference call is only going to be open to brokers and money managers,because of the large numbers,Darby had to cut it somewhere.I will post conference call in detail right afterwards.I apologize to all of the loyal supporters on this thread that might not hear it firsthand,but I should not have opened my big mouth about it.
Now,to my impressions of what is going on.The fact that I am a big fan of Darby's is no real revelation to long time followers,but let me tell you my opinion went up 300% after Thursday and Friday.This lady borned this company,developed the product,got it through the FDA,and is now ready to put it on the launch pad.
I have often been accused of hype on these boards,and I guess I stand convicted.So,let me add to the hype.We are going to have 2 companies,a medical company,and a consumer company.The markets that both of these will serve is mind boggling,but I will wait and hear what Darby says on Tuesday.
This to me is like buying USS,SDG,MDTor STJ 10 years ago,new products in very large markets.the one difference right now is lack of competition in the Bilirubin market,which is worldwide in scope.I would not be suprised to see this product in every country in the world in 3 years. That is a lot of babies.What is kind of neat is a product with worldwide demand,much cheaper,which insurance companies will love,as accurate,non-invasive,can be used
in harsh environments where blood testing is not very acceptable or practical.
As for cosmetics and dental,no FDA required,just ability to produce in quantity.I believe this market is equal to or greater than medical.
No Wall Street coverage.(YET).No publicity anywhere (yet),relatively small float,potential box car sales and earning for the future,in an industry,medical instruments, devices that carries a very large p/e ratio.35x-40x.A technician friend of mine said CCSI's chart reminds him of CREE,DATM at the same stage when we got involved a few years ago.
|
